Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBRX
526
LB Pharmaceuticals
LBRX
$1.54B
| $29.9M | 0.04% |
921,471
-2,223
| -0.2% | -$65.3K |
|
|
527
CALL
Roku
ROKU
$23.4B
| $29.8M | 0.04% |
215,800
+150,400
| +230% | +$18.3M |
|
|
VMRK
528
Vivmark Residential
VMRK
$25B
| $29.8M | 0.04% |
438,236
+433,104
| +8,439% | +$28M |
|
529
Organon & Co
OGN
$3.61B
| $29.7M | 0.04% |
2,196,642
+1,978,742
| +908% | +$23.7M |
|
530
Live Nation Entertainment
LYV
$42.4B
| $29.6M | 0.04% |
161,795
-351,423
| -68% | -$57.8M |
|
531
Hormel Foods
HRL
$13.1B
| $29.6M | 0.04% |
+1,193,319
| New | +$26.5M |
|
532
PUT
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $29.5M | 0.04% |
+155,000
| New | +$26.5M |
|
533
Verisk Analytics
VRSK
$24.4B
| $29.5M | 0.04% |
164,439
+89,160
| +118% | +$15.7M |
|
534
On Holding
ONON
$10B
| $29.5M | 0.04% |
832,377
-1,044,862
| -56% | -$38.2M |
|
535
Hubbell
HUBB
$24.8B
| $29.4M | 0.04% |
56,271
-12,948
| -19% | -$6.54M |
|
536
PUT
Union Pacific
UNP
$183B
| $29.4M | 0.04% |
108,000
+36,800
| +52% | +$9.66M |
|
537
Columbia Banking Systems
COLB
$8.72B
| $29.3M | 0.04% |
913,570
-366,493
| -29% | -$10.9M |
|
|
STUB
538
StubHub Holdings
STUB
$2.55B
| $29.1M | 0.04% |
+2,257,906
| New | +$19.9M |
|
|
CDNL
539
Cardinal Infrastructure Group
CDNL
$889M
| $28.5M | 0.04% |
302,634
+192,841
| +176% | +$11.1M |
|
|
WBI
540
WaterBridge Infrastructure LLC
WBI
$1.76B
| $28.5M | 0.04% |
831,453
+812,377
| +4,259% | +$23.6M |
|
|
JHG
541
DELISTED
Janus Henderson
JHG
| $28.5M | 0.04% |
548,203
+2,128
| +0.4% | +$110K |
|
542
Alexandria Real Estate Equities
ARE
$9.21B
| $28.3M | 0.04% |
+536,294
| New | +$25.7M |
|
543
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $28.1M | 0.04% |
176,900
+23,500
| +15% | +$3.5M |
|
544
Sagimet Biosciences
SGMT
$637M
| $28M | 0.03% |
+3,626,113
| New | +$24.7M |
|
545
California Resources
CRC
$4.73B
| $28M | 0.03% |
529,735
+229,459
| +76% | +$14.1M |
|
546
Saia
SAIA
$9.66B
| $28M | 0.03% |
66,470
-44,387
| -40% | -$19.5M |
|
547
Biohaven
BHVN
$2.09B
| $28M | 0.03% |
1,879,734
-565,682
| -23% | -$6.09M |
|
548
Baker Hughes
BKR
$61.9B
| $27.9M | 0.03% |
503,321
-1,758,738
| -78% | -$111M |
|
549
CALL
Procter & Gamble
PG
$336B
| $27.9M | 0.03% |
190,400
+165,600
| +668% | +$24.1M |
|
550
CALL
Boeing
BA
$169B
| $27.8M | 0.03% |
128,200
+99,200
| +342% | +$22.1M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.